Barely Significant
← all excerpts

BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAF<sup>V600E</sup>-mutant glioma.

Cell Rep Med · 2025 · PMC12208339 · PMID 40505659

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

showed a trendno p-value reported
80 ICI 1 st showed a trend for improved survival over BRAFi+MEKi 1 st , which provided no survival benefit over BRAFi+MEKi treatment alone.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.